No intervention
OtherEvaluation of natural history of the disease
NCT Number: NCT07095829
Pulmonary atresia (PA)/critical stenosis (CS) with intact ventricular septum (PA/CS-IVS) is a rare congenital heart disease (CHD), that presents heterogeneously. Prognosis is conditioned by the possibility of achieving a primary repair with biventricular circulation (BV) or a one-and-a-half ventricle solution vs. a palliative approach bound to a univentricular (UV) circulation in which both survival and quality of life are significantly impaired. Predicting UV circulation prenatally is still a challenge.
The aim of this study is: 1/ to evaluate the natural history of the disease and develop a prognostic model for the prediction of transplantation-free survival with a biventricular or a one-and-a-half repair at 2 years postnatal age 2/ To develop a model to predict the risk of right ventricle dependent coronary circulation 3/ To evaluate prenatal and postnatal outcomes in non-intervened fetuses with a confirmed postnatal diagnosis of PA-CS/IVS including Intrauterine death, neonatal/Infant death, number of required postnatal procedures, need for oxygen support, need for cardiac transplantation
Interested in participating?
Request Info16 week–28 week
All sexes
Observational
Hospital Universitario 12 de Octubre, Madrid, Spain
This is an international retrospective and prospective observational cohort study including non-intervened fetuses with a diagnosis of PA-CS/IVS between 16+0 and 28+6 weeks of gestation.
A baseline fetal ultrasound examination will be recorded for all included cases. The primary aim of the study is to develop a prognostic and validate model for the type of postnatal circulation (transplantation-free survival with a biventricular or a one-and-a-half repair at 2 years postnatal age vs univentricular palliation or transplanted).
In order to maximize the number of included cases in this rare entity, the model will be developed on retrospective data from 2013 until 2023 and validated in a prospective cohort. Cases will be recruited in referral centers regardless of their offering of fetal pulmonary valvuloplasty. However, only non-prenatally-intervened cases will be used for analysis. Fetal and postnatal echocardiographic examinations will be reviewed by a core laboratory to confirm eligibility for inclusion and identify potential measurement errors.
Data from at least one fetal echo (the first diagnostic evaluation at the referral center) and one postnatal (the first one performed after birth) will be collected, each containing a comprehensive set of two-dimensional and Doppler measurements. Additionally, one additional follow-up scan performed at least 8 weeks apart from the baseline diagnostic scan (ideally between 28 and 32 weeks) will be included in the study as well. Analysis of the prenatal change of dimensions of the right heart structures and selected hemodynamic parameters will enable comparisons between centers regardless of off-protocol center-specific postnatal treatment policies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Evaluation of natural history of the disease
Time frame: 3 years (1 recruitment, 2 follow-up)
Transplantation-free survival with a non-univentricular circulation (biventricular or a one-and-a-half repair) at 2 years postnatal age: yes/no
Time frame: 3 years (1 recruitment, 2 follow-up)
Prediction of right ventricle-dependent coronary circulation confirmed by cath or autopsy (yes/no)
Time frame: 3 years (1 recruitment, 2 follow-up)
Intrauterine death (yes/no)
Time frame: 3 years (1 recruitment, 2 follow-up)
Neonatal/Infant death in the first 2 years (yes/no)
Time frame: 3 years (1 recruitment, 2 follow-up)
Number of required postnatal surgical and catheter interventional procedures
Time frame: 3 years (1 recruitment, 2 follow-up)
Type of required postnatal surgical and catheter interventional procedures
Time frame: 3 years (1 recruitment, 2 follow-up)
O2 saturation at 30 days (%)
Time frame: 3 years (1 recruitment, 2 follow-up)
Transplantation in the first two years (yes/no)
Contact information is provided by the study sponsor or research team.
Alberto Galindo, MD PhD
CONTACT
Cecilia Villalain, MD PhD
CONTACT
Hospital Universitario 12 de Octubre
Other
Development and Validation of a Prognostic Model of Postnatal Circulation in Fetuses With a Diagnosis of Pulmonary Atresia-critical Stenosis With Intact Ventricular Septum A Prospective Observational Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05928234
Pulmonary Atresia With Intact Ventricular Septum, Pulmonary Atresia with Intact Ventricular Septum
Gothenburg, Sweden
View Trial DetailsNCT03775954
Anemia, Anemia, Neonatal
Madison, Wisconsin, United States
View Trial DetailsNCT05386173
Aortic Valve Disease, Aortic Valve Stenosis
San Francisco, California, United States
View Trial DetailsNCT06711666
Behavior, Behavioral Symptoms
Marseille, France
View Trial Details